- Home
- COGT vs TEN Comparison
COGT vs TEN Comparison
Compare COGT & TEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- TEN
- Stock Information
- Founded
- COGT 2014
- TEN 1993
- Country
- COGT United States
- TEN Greece
- Employees
- COGT N/A
- TEN N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- TEN
- Sector
- COGT Health Care
- TEN
- Exchange
- COGT Nasdaq
- TEN NYSE
- Market Cap
- COGT 545.3M
- TEN 480.8M
- IPO Year
- COGT 2018
- TEN N/A
- Fundamental
- Price
- COGT $4.81
- TEN $17.51
- Analyst Decision
- COGT Buy
- TEN Buy
- Analyst Count
- COGT 7
- TEN 2
- Target Price
- COGT $14.00
- TEN $31.00
- AVG Volume (30 Days)
- COGT 1.3M
- TEN 257.9K
- Earning Date
- COGT 05-06-2025
- TEN 05-23-2025
- Dividend Yield
- COGT N/A
- TEN 8.56%
- EPS Growth
- COGT N/A
- TEN N/A
- EPS
- COGT N/A
- TEN 5.03
- Revenue
- COGT N/A
- TEN $804,061,000.00
- Revenue This Year
- COGT N/A
- TEN N/A
- Revenue Next Year
- COGT N/A
- TEN $11.19
- P/E Ratio
- COGT N/A
- TEN $3.42
- Revenue Growth
- COGT N/A
- TEN N/A
- 52 Week Low
- COGT $3.72
- TEN $13.40
- 52 Week High
- COGT $12.61
- TEN $31.48
- Technical
- Relative Strength Index (RSI)
- COGT 44.64
- TEN 58.95
- Support Level
- COGT $4.55
- TEN $17.02
- Resistance Level
- COGT $5.89
- TEN $17.73
- Average True Range (ATR)
- COGT 0.38
- TEN 0.57
- MACD
- COGT 0.09
- TEN 0.14
- Stochastic Oscillator
- COGT 34.55
- TEN 78.47
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About TEN TSAKOS ENERGY NAVIGATION
Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.